Pfizer and BioNTech recently submitted data to the FDA supporting a third booster dose for their COVID-19 vaccine.
The FDA and CDC soon thereafter announced plans to move forward with third booster doses for mRNA vaccines.
The most compelling reason for giving a green light for booster doses wasn't Pfizer's data but instead the number of COVID-19 cases for vaccinated Americans.
